{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-152866","form_type":"8-K","ticker":"ALLO","cik":"0001737287","company_name":"Allogene Therapeutics, Inc.","filed_at":"2026-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.829319+00:00","generated_at":"2026-05-15T06:35:47.016587+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Allogene Therapeutics launches underwritten public offering, suspends ATM sales","bullets":["Company announced proposed underwritten public offering of common stock on April 13, 2026.","Sales under existing ATM agreement with TD Securities are suspended pending new prospectus.","No offering size or pricing details disclosed in the 8-K; further supplement expected.","Proceeds intended for general corporate purposes; dilution to existing shareholders anticipated."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-152866","json":"https://secwatch.observer/filing/0001193125-26-152866.json","markdown":"https://secwatch.observer/filing/0001193125-26-152866.md","text":"https://secwatch.observer/filing/0001193125-26-152866.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737287/000119312526152866/0001193125-26-152866-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737287/000119312526152866/d249901d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:35:47.016587+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}